Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptiNose, Inc. - Common Stock (NQ: OPTN )

5.360 -0.010 (-0.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,523
Open 5.400
Bid (Size) 5.250 (20)
Ask (Size) 8.600 (2)
Prev. Close 5.370
Today's Range 5.330 - 5.473
52wk Range 4.815 - 31.50
Shares Outstanding 53,309,012
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Conference Call and Webcast to be held March 20, 2025, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Monday's pre-market session: top gainers and losers
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill

Performance

YTD
-20.00%
-20.00%
1 Month
-2.72%
-2.72%
3 Month
-26.82%
-26.82%
6 Month
-61.78%
-61.78%
1 Year
-81.49%
-81.49%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Insights Ahead: OptiNose's Quarterly Earnings
Via Benzinga
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces 1-for-15 Reverse Stock Split
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
From Optinose, Inc.
Via GlobeNewswire
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Optinose, Inc.
Via GlobeNewswire
Optinose Appoints Terry Kohler as Chief Financial Officer
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Optinose, Inc.
Via GlobeNewswire
OPTN Stock Earnings: OptiNose Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
From Optinose, Inc.
Via GlobeNewswire
7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
Via InvestorPlace
Expanded Access to XHANCE with Addition to National Commercial Formularies
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
From Optinose, Inc.
Via GlobeNewswire
Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.